Technical Analysis for MLND - Millendo Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 10.37 9.97% 0.94
MLND closed up 9.97 percent on Thursday, January 17, 2019, on 1.31 times normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical MLND trend table...

Date Alert Name Type % Chg
Jan 17 Crossed Above 50 DMA Bullish 0.00%
Jan 17 Stochastic Reached Overbought Strength 0.00%
Jan 17 Multiple of Ten Bullish Other 0.00%
Jan 17 Wide Bands Range Expansion 0.00%
Jan 17 Above Upper BB Strength 0.00%
Jan 17 Overbought Stochastic Strength 0.00%
Jan 17 Up 3 Days in a Row Strength 0.00%
Jan 17 Upper Bollinger Band Touch Strength 0.00%
Jan 16 Wide Bands Range Expansion 9.97%
Jan 15 Wide Bands Range Expansion 17.84%

Older signals for MLND ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Millendo Therapeutics is a late-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases where current therapies do not exist or are insufficient. The Company’s objective is to build a leading endocrine company that creates distinct and transformative treatments for a wide range of endocrine diseases where there is a significant unmet medical need. The Company is currently advancing livoletide for the treatment of Prader-Willi syndrome and nevanimibe for the treatment of classic congenital adrenal hyperplasia and endogenous Cushing’s syndrome.
Is MLND a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 17.4
52 Week Low 6.77
Average Volume 12,262
200-Day Moving Average 11.9465
50-Day Moving Average 9.6778
20-Day Moving Average 8.2758
10-Day Moving Average 8.846
Average True Range 0.952
ADX 21.79
+DI 30.5275
-DI 13.8717
Chandelier Exit (Long, 3 ATRs ) 8.124
Chandelier Exit (Short, 3 ATRs ) 9.626
Upper Bollinger Band 9.8798
Lower Bollinger Band 6.6718
Percent B (%b) 1.15
BandWidth 38.763624
MACD Line -0.074
MACD Signal Line -0.3722
MACD Histogram 0.2981
Fundamentals Value
Market Cap 370.09 Million
Num Shares 35.7 Million
EPS -2.11
Price-to-Earnings (P/E) Ratio -4.91
Price-to-Sales 116.65
Price-to-Book 0.67
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.56
Resistance 3 (R3) 12.46 11.63 12.20
Resistance 2 (R2) 11.63 11.07 11.68 12.07
Resistance 1 (R1) 11.00 10.72 11.31 11.10 11.95
Pivot Point 10.17 10.17 10.32 10.22 10.17
Support 1 (S1) 9.54 9.61 9.85 9.64 8.79
Support 2 (S2) 8.71 9.26 8.76 8.67
Support 3 (S3) 8.08 8.71 8.54
Support 4 (S4) 8.18